Medicare Cancer Demo May Encourage Use Of EPO, Anti-Emetics
This article was originally published in The Pink Sheet Daily
Executive Summary
The Medicare program is earmarking $300 mil. for a "quality of care" demonstration project that should help smooth the transition to ASP-based reimbursement in 2005
You may also be interested in...
Reduced Cancer Drug Reimbursements Don’t Impede Access – JAMA Study
2003-2006 Medicare claim review finds no evidence that lowering physician payments adversely affected access to care.
Reduced Cancer Drug Reimbursements Don’t Impede Access – JAMA Study
2003-2006 Medicare claim review finds no evidence that lowering physician payments adversely affected access to care.
CMS Cancer "Quality Of Care" Data Show "A Lot Of Variations," McClellan Says
Preliminary data from the oncology demonstration project show variable quality-of-life outcomes, likely because many patients have late-stage cancer, CMS Administrator McClellan says. The program may ultimately help drive improvements in clinical practices, he predicts.